Jaguar Health (JAGX) Raw Materials (2018 - 2026)

Jaguar Health (JAGX) has 9 years of Raw Materials data on file, last reported at $4.9 million in Q1 2026.

• Raw Materials for Q1 2026 came in at $4.9 million, up 160.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.9 million (up 160.82% YoY), and the FY2025 annual result was $5.2 million, down 29.31% from the prior year.
• Raw Materials retreated to $4.9 million in Q1 2026 per JAGX's latest filing, from $5.2 million in the prior quarter.
• Over five years, Raw Materials peaked at $7.4 million in Q4 2024 and troughed at $1.6 million in Q1 2022.
• A 5-year average of $2.7 million and a median of $2.0 million in 2023 frame the typical range for Raw Materials.
• The sharpest annual moves came in 2024 and 2025: Raw Materials jumped 260.09% in 2024, then dropped 29.31% in 2025.
• A 5-year view of Raw Materials shows it stood at $2.1 million in 2022, then decreased by 2.09% to $2.1 million in 2023, then jumped by 260.09% to $7.4 million in 2024, then fell by 29.31% to $5.2 million in 2025, then dropped by 6.3% to $4.9 million in 2026.
• Business Quant data shows JAGX's Raw Materials at $4.9 million in Q1 2026, $5.2 million in Q4 2025, and $2.0 million in Q3 2025.